Neurizon Therapeutics Limited (ASX:NUZ)
Australia
· Delayed Price · Currency is AUD 0.1600
+0.0050 (3.23%)
At close: Jul 4, 2025, 4:00 PM AEST
Neurizon Therapeutics Market Cap
Neurizon Therapeutics has a market cap or net worth of 76.31 million as of July 3, 2025. Its market cap has decreased by -5.98% in one year.
Market Cap
76.31M
Enterprise Value
66.19M
Revenue
1.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
Market Cap Chart
Since September 12, 2002, Neurizon Therapeutics's market cap has increased from 4.18M to 76.31M, an increase of 1,724.14%. That is a compound annual growth rate of 13.57%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 115.36B |
| Pro Medicus | 29.43B |
| Cochlear | 19.92B |
| Sonic Healthcare | 13.21B |
| Ramsay Health Care | 8.63B |
| Telix Pharmaceuticals | 8.14B |
| Ansell | 4.46B |
| Imugene | 3.55B |